Skip to main content
OpenTrials

Clinical trial condition

Endocrine Gland Neoplasms

Explore clinical trials studying Endocrine Gland Neoplasms. Study availability and eligibility vary by location and protocol.

6,077 public trials 1,365 recruiting studies
Refine in advanced search Browse all conditions

Endocrine Gland Neoplasms trial results

Recruiting

Improving Care for Rural Patients With Solid Tumors

NCT04916990

Conditions
Bladder Cancer, Breast Cancer, Breast Diseases, +48 more
Locations
  • University of Colorado Hospital Aurora, Colorado, United States
  • Memorial Hospital Central Colorado Springs, Colorado, United States
  • Memorial Hospital North Colorado Springs, Colorado, United States
  • Poudre Valley Hospital Fort Collins, Colorado, United States
View all 14 locations
View Trial Details
Recruiting

A Study of MGC026 in Participants With Advanced Solid Tumors

NCT06242470

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +102 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • START Midwest Grand Rapids, Michigan, United States
  • START-New York Long Island Lake Success, New York, United States
  • Providence Cancer Institute Portland, Oregon, United States
View Trial Details
Recruiting

Germ Cell Tumor and Testicular Tumor DNA Registry

NCT02099734

Conditions
Endocrine Gland Neoplasms, Endocrine System Diseases, Genital Diseases, +14 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Cold Springs Harbor Laboratory (Specimen Analysis) Cold Spring Harbor, New York, United States
View Trial Details
Recruiting

Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE)

NCT03017573

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +32 more
Locations
  • Institut Bergonie Bordeaux, France
  • Centre Oscar Lambret Lille, France
  • Centre Leon Berard Lyon, France
  • Institut Curie Paris, France
View Trial Details
Recruiting

A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers

NCT06469281

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • John Theurer Cancer Center Hackensack University Medical Center Hackensack, New Jersey, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
View Trial Details

Related conditions